XPD mutations found in most patients with XP-D alter the ability of XPD to interact with Eg5 (Fig. 3A), which consequently disrupt the localization of Eg5 on microtubules, as observed in XPD/R683W-deficient cells (Fig. 5, A and C). This evidence concerns the gene KIF11 and xeroderma pigmentosum group D.